Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipid free radicals are highly reactive chemical species, such as lipid peroxyl (LOO•) and alkoxyl (LO•) radicals, produced during the oxidative degradation of lipids, particularly polyunsaturated fatty acids (Ayala et al., 2014, Oxidative Medicine and Cellular Longevity). These radicals drive the process of lipid peroxidation, a self-propagating chain reaction that disrupts cellular membrane integrity and generates toxic secondary products like malondialdehyde and 4-hydroxynonenal (Gaschler & Stockwell, 2017, Nature Chemical Biology). In a pathological context, the accumulation of lipid radicals is a hallmark of ferroptosis, an iron-dependent form of regulated cell death linked to neurodegeneration, cancer, and ischemia-reperfusion injury (Dixon et al., 2012, Cell). Therapeutic strategies target these radicals through chain-breaking antioxidants, such as alpha-tocopherol (Vitamin E), or specialized scavengers like edaravone, which is used clinically to treat amyotrophic lateral sclerosis (Yoshino & Itoh, 2013, CNS Neuroscience & Therapeutics). By neutralizing lipid radicals, these agents prevent the cascade of oxidative damage and protect cells from ferroptotic death (Conrad et al., 2018, Nature Chemical Biology).
Chain-breaking antioxidant activity that terminates the propagation of lipid peroxidation by donating a hydrogen atom to lipid peroxyl radicals, thereby forming a stable non-radical product.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid free radical (L•).